Jul 22, 2025 / 07:00AM GMT
Operator
Welcome to Embla Medical conference call for Q2 2025. Today's call is being recorded. (Operator Instructions)
I would now like to introduce President and CEO, Sveinn Solvason; and CFO, Arna Sveinsdottir. Please begin your presentation.
Sveinn Solvason - Embla Medical hf - President, Chief Executive Officer
Thank you very much, and good morning, and welcome to the Embla Medical conference call where we will review the second quarter of 2025. I'm Sveinn Solvason, President and CEO of Embla Medical. Joining me on today's call is our Chief Financial Officer, Arna Sveinsdottir; and Embla Medical's Head of Investor Relations, Klaus Sindahl. The presentation should take approximately 15 minutes, after which there will be an opportunity to ask questions during a Q&A session.
If we could go to the next slide, please. Sales in the second quarter amounted to $232 million, representing 7% reported growth of which 5% was organic. Both were strong in the Prosthetics and Neuro Orthotics segment, mainly driven by the continued momentum in EMEA and
Q2 2025 Embla Medical hf Earnings Call Transcript
1 day ago
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers